Entrada Therapeutics, Inc.
TRDA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $66 | -$7 | -$95 | -$51 |
| Dep. & Amort. | $4 | $3 | $2 | $1 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $18 | $13 | $0 | $3 |
| Change in WC | -$119 | $136 | -$11 | -$3 |
| Other Non-Cash | -$10 | -$6 | $10 | $0 |
| Operating Cash Flow | -$42 | $140 | -$94 | -$51 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$3 | -$6 | -$3 | -$5 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$438 | -$407 | -$222 | $0 |
| Inv. Sales/Matur. | $413 | $274 | $76 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$28 | -$138 | -$149 | -$5 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $100 | $19 | $0 | $191 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $3 | $2 | $0 | $117 |
| Financing Cash Flow | $103 | $21 | $0 | $307 |
| Forex Effect | $0 | $0 | -$4 | $0 |
| Net Chg. in Cash | $34 | $22 | -$246 | $252 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $72 | $49 | $291 | $39 |
| End Cash | $105 | $72 | $45 | $291 |
| Free Cash Flow | -$45 | $134 | -$97 | -$55 |